| Enabling precision manufacturing of active pharmaceutical ingredients: workflow for seeded cooling continuous crystallisations CJ Brown, T McGlone, S Yerdelen, V Srirambhatla, F Mabbott, R Gurung, ... Molecular Systems Design & Engineering 3 (3), 518-549, 2018 | 102 | 2018 |
| Isomorphous template induced crystallisation: a robust method for the targeted crystallisation of computationally predicted metastable polymorphs VK Srirambhatla, R Guo, SL Price, AJ Florence Chemical Communications 52 (46), 7384-7386, 2016 | 70 | 2016 |
| Successful computationally directed templating of metastable pharmaceutical polymorphs DH Case, VK Srirambhatla, R Guo, RE Watson, LS Price, H Polyzois, ... Crystal Growth & Design 18 (9), 5322-5331, 2018 | 67 | 2018 |
| Crystal design approaches for the synthesis of paracetamol co-crystals VK Srirambhatla, A Kraft, S Watt, AV Powell Crystal growth & design 12 (10), 4870-4879, 2012 | 45 | 2012 |
| Tautomerism unveils a self-inhibition mechanism of crystallization W Tang, T Yang, CA Morales-Rivera, X Geng, VK Srirambhatla, X Kang, ... Nature Communications 14 (1), 561, 2023 | 31 | 2023 |
| Reversible, two-step single-crystal to single-crystal phase transitions between desloratadine forms I, II, and III VK Srirambhatla, R Guo, DM Dawson, SL Price, AJ Florence Crystal Growth & Design 20 (3), 1800-1810, 2020 | 26 | 2020 |
| A robust two-dimensional hydrogen-bonded network for the predictable assembly of ternary co-crystals of furosemide VK Srirambhatla, A Kraft, S Watt, AV Powell CrystEngComm 16 (43), 9979-9982, 2014 | 23 | 2014 |
| 4: 3 naltrexone: 5-methyl-2-furaldehyde cocrystal R Barbier, N Friedman, V Srirambhatla, S Watt, M Zamloot US Patent 9,623,017, 2017 | 13 | 2017 |
| Prediction of mefenamic acid crystal shape by random forest classification S Nakapraves, M Warzecha, CL Mustoe, V Srirambhatla, AJ Florence Pharmaceutical Research 39 (12), 3099-3111, 2022 | 10 | 2022 |
| Crystal structure and twisted aggregates of oxcarbazepine form III H Polyzois, R Guo, VK Srirambhatla, M Warzecha, E Prasad, A Turner, ... Crystal Growth & Design 22 (7), 4146-4156, 2022 | 3 | 2022 |
| Cocrystals of naloxone and naltrexone R Barbier, N Friedmann, V Srirambhatla, S Watt, M Zamloot US Patent 11,096,936, 2021 | 2 | 2021 |
| Molecular Systems Design & Engineering CJ Brown, T McGlone, S Yerdelen, V Srirambhatla, F Mabbott, R Gurung, ... | 1 | 2018 |
| Machine learning workflows to predict crystallisability, glass forming ability, mechanical properties of small organic compounds VK Srirambhatla, B Johnston, A Florence CMAC Annual Open Day 2022, 2022 | | 2022 |
| Crystalline salts of naloxone and naltrexone R Barbier, N Friedmann, V Srirambhatla, S Watt, M Zamloot US Patent 10,980,799, 2021 | | 2021 |
| Template induced targeted crystallisation of computationally predicted polymorphs. VK Srirambhatla, R Guo, SL Price, AJ Florence Acta Cryst 70, C1414, 2017 | | 2017 |
| Co-crystallisation of active pharmaceutical ingredients VK Srirambhatla Engineering and Physical Sciences, 2014 | | 2014 |
